These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33895019)

  • 1. Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.
    Mohammadi M; IJzerman NS; Hohenberger P; Rutkowski P; Jones RL; Martin-Broto J; Gronchi A; Schöffski P; Vassos N; Farag S; Baia M; Oosten AW; Steeghs N; Desar IME; Reyners AKL; van Sandick JW; Bastiaannet E; Gelderblom H; Schrage Y
    Eur J Surg Oncol; 2021 Aug; 47(8):2173-2181. PubMed ID: 33895019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG).
    Duffaud F; Meeus P; Bertucci F; Delhorme JB; Stoeckle E; Isambert N; Bompas E; Gagniere J; Bouché O; Toulmonde M; Salas S; Blay JY; Bonvalot S;
    Eur J Surg Oncol; 2017 Jun; 43(6):1110-1116. PubMed ID: 28433494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors.
    Shi HP; Huang ML; Wang ZQ; Zheng YN; Zhu ZL; Sah BK; Liu WT; Yan M; Zhu ZG; Li C
    Dig Surg; 2018; 35(6):498-507. PubMed ID: 29232679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.
    Bertsimas D; Margonis GA; Sujichantararat S; Koulouras A; Ma Y; Antonescu CR; Brennan MF; Martín-Broto J; Tang S; Rutkowski P; Kreis ME; Beyer K; Wang J; Bylina E; Sobczuk P; Gutierrez A; Jadeja B; Tap WD; Chi P; Singer S
    Lancet Oncol; 2024 Aug; 25(8):1025-1037. PubMed ID: 38976997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of esophageal gastrointestinal stromal tumor: review of one hundred seven patients.
    Pence K; Correa AM; Chan E; Khaitan P; Hofstetter W; Kim MP
    Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally Invasive Resection of Large Gastric Gastrointestinal Stromal Tumors.
    Gertsen EC; van Boxel GI; Brosens LAA; Ruurda JP; van Hillegersberg R
    Dig Surg; 2020; 37(6):441-446. PubMed ID: 32980837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.
    Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP
    Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal gastrointestinal stromal tumor: is tumoral enucleation a viable therapeutic option?
    Robb WB; Bruyere E; Amielh D; Vinatier E; Mabrut JY; Perniceni T; Piessen G; Mariette C;
    Ann Surg; 2015 Jan; 261(1):117-24. PubMed ID: 25062398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.
    Hohenberger P; Bonvalot S; van Coevorden F; Rutkowski P; Stoeckle E; Olungu C; Litiere S; Wardelmann E; Gronchi A; Casali P
    Eur J Cancer; 2019 Oct; 120():47-53. PubMed ID: 31479947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis.
    Bischof DA; Dodson R; Jimenez MC; Behman R; Cocieru A; Blazer DG; Fisher SB; Squires MH; Kooby DA; Maithel SK; Groeschl RT; Gamblin TC; Bauer TW; Karanicolas PJ; Law C; Quereshy FA; Pawlik TM
    J Gastrointest Surg; 2015 Jun; 19(6):1022-8. PubMed ID: 25731828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
    Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
    Cavnar MJ; Seier K; Gönen M; Curtin C; Balachandran VP; Tap WD; Antonescu CR; Singer S; DeMatteo RP
    J Gastrointest Surg; 2021 Jul; 25(7):1828-1836. PubMed ID: 33169327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
    Raut CP; Espat NJ; Maki RG; Araujo DM; Trent J; Williams TF; Purkayastha DD; DeMatteo RP
    JAMA Oncol; 2018 Dec; 4(12):e184060. PubMed ID: 30383140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large esophageal gastrointestinal stromal tumors resected thoracoscopically after oral imatinib therapy: a report of two cases.
    Kurosaki T; Hoshino I; Kuwayama N; Suitou H; Kano M; Tonooka T; Chiba S; Soda H; Nabeya Y; Takayama W
    Clin J Gastroenterol; 2023 Apr; 16(2):136-141. PubMed ID: 36547850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
    Wilkinson MJ; Fitzgerald JE; Strauss DC; Hayes AJ; Thomas JM; Messiou C; Fisher C; Benson C; Tekkis PP; Judson I
    Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcome of gastrointestinal stromal tumors of the duodenum.
    Chung JC; Chu CW; Cho GS; Shin EJ; Lim CW; Kim HC; Song OP
    J Gastrointest Surg; 2010 May; 14(5):880-3. PubMed ID: 20140534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients.
    Farag S; Somaiah N; Choi H; Heeres B; Wang WL; van Boven H; Nederlof P; Benjamin R; van der Graaf W; Grunhagen D; Boonstra PA; Reyners AK; Gelderblom H; Steeghs N
    Eur J Cancer; 2017 May; 76():76-83. PubMed ID: 28284172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.